Shareholding disclosure

Stichting Pensioenfonds ABP

Declared position

3.011%

Threshold

Crossed upwards

Timeline

Published

24.02.2009

Transaction

18.02.2009

Voting rights breakdown

Voting rights acquired3.011%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TA92N00015

Beneficial owner

Stichting Pensioenfonds ABP

Declared address

Stichting Pensioenfonds ABP, 6401 JS Heerlen

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Stichting Pensioenfonds ABP

Kuros Biosciences AG24.02.2009TA92N00015

Disclosure summary

Stichting Pensioenfonds ABP disclosed a holding in Kuros Biosciences AG on the acquisition side, published by SIX Exchange Regulation on 24.02.2009, at 3.011% of voting rights. Notice category: Single shareholder.

Disclosed position

3.011%

Voting rights acquired

Voting rights acquired3.011%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Stichting Pensioenfonds ABP disclosed a holding in Kuros Biosciences AG, published on 24.02.2009.

Publication date24.02.2009

Transaction date18.02.2009

Issuing companyKuros Biosciences AG

Beneficial ownerStichting Pensioenfonds ABP

Declared addressStichting Pensioenfonds ABP, 6401 JS Heerlen

CategorySingle shareholder

Voting rights acquired3.011%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTA92N00015

Source: SIX Exchange Regulation · Publication date: 24.02.2009

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open